Resources from the same session
5681 - A Phase Ib/2 study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced Urothelial Cancer (UC)
Presenter: Christopher Hoimes
Session: Poster Discussion session - Genitourinary tumours, non prostate
Resources:
Abstract
1202 - RANGE, a phase 3, randomized, placebo-controlled, double-blind trial of ramucirumab (RAM) and docetaxel (DOC) in platinum-refractory urothelial carcinoma (UC): overall survival results
Presenter: Daniel Petrylak
Session: Poster Discussion session - Genitourinary tumours, non prostate
Resources:
Abstract
4306 - Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): prospective analysis from the GETUG-AFU 26 (NIVOREN) trial
Presenter: Ronan Flippot
Session: Poster Discussion session - Genitourinary tumours, non prostate
Resources:
Abstract
Poster Discussion session - Genitourinary tumours, non prostate - Invited Discussant LBA33, 865PD and 868PD
Presenter: Rob Jones
Session: Poster Discussion session - Genitourinary tumours, non prostate
4017 - Comprehensive biomarker analyses and updated results of PURE-01 study: neoadjuvant pembrolizumab (Pembro) in muscle-invasive urothelial bladder carcinoma (MIBC).
Presenter: Andrea Necchi
Session: Poster Discussion session - Genitourinary tumours, non prostate
Resources:
Abstract
2675 - Comprehensive genomic profiling (CGP) of chemotherapy-resistant, primary mediastinal nonseminomatous germ cell tumors (PMNSGCT)
Presenter: Andrea Necchi
Session: Poster Discussion session - Genitourinary tumours, non prostate
Resources:
Abstract
4057 - PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials.
Presenter: Toni Choueiri
Session: Poster Discussion session - Genitourinary tumours, non prostate
Resources:
Abstract
1957 - Tumor molecular characteristics in patients (pts) with International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) good (G) and intermediate/poor (I/P) risk
Presenter: Benoit Beuselinck
Session: Poster Discussion session - Genitourinary tumours, non prostate
Resources:
Abstract
1701 - Efficacy and safety of axitinib in metastatic papillary renal carcinoma (mPRC): results of a GETUG multicenter phase II trial (Axipap)
Presenter: Sylvie Negrier
Session: Poster Discussion session - Genitourinary tumours, non prostate
Resources:
Abstract
Poster Discussion session - Genitourinary tumours, non prostate - Invited Discussant LBA34, 869PD and 870PD
Presenter: Cristina Suarez
Session: Poster Discussion session - Genitourinary tumours, non prostate
Resources:
Slides
Webcast